SAT0153 Early response to infliximab therapy predicts long-term disease activity outcomes in patients with rheumatoid arthritis: Results from the czech national biological therapy registry (ATTRA)
SAT0153 Early response to infliximab therapy predicts long-term disease activity outcomes in patients with rheumatoid arthritis: Results from the czech national biological therapy registry (ATTRA)